CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 5,127 enrolled
Drug / intervention
FIT kit Screening Test +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05714644
NCT05714644N/ACompleted
CompareCT.gov

Community Collaboration to Advance Racial/Ethnic Equity in CRC Screening

Massachusetts General Hospital·interventional·Posted Feb 6, 2023·Updated Dec 26, 2025

In Brief

A clinical study evaluating FIT kit Screening Test and Cologuard Screening Test for Colorectal Cancer. Completed, enrolled 5,127 participants across 3 sites.

Detailed Summary

The goal of this pragmatic randomized clinical trial is to compare two colorectal (CRC) screening outreach approaches (FIT and Cologuard) in community health centers (CHC) in patients overdue for CRC screening. The main questions the project aims to answer are: What screening test has a higher completion rate? What screening test is more feasible and acceptable in a CHC setting? Patients will be sent a CRC screening test in the mail and will be asked to complete it at home and mail it back. Researchers will compare the completion rates for each screening test and will also look at the overall completion rate of both tests.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsColorectal Cancer
CountriesUnited States
CollaboratorsStand Up To Cancer, University of California, Los Angeles, Great Plains Tribal Leaders Health Board

Timeline

N/ACompletedFinished
202420252026
First PostedFeb 6, 2023
Enrollment StartJun 7, 2023
Primary CompletionJun 30, 2024
Study CompletionSep 30, 2025
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 3.4 years ago

Interventions

FIT kit Screening Testother

FIT kit mailed to the patient's home

Cologuard Screening Testother

Cologuard test mailed to the patient's home